HighTower Advisors LLC Buys 4,047 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

HighTower Advisors LLC grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.1% in the fourth quarter, HoldingsChannel.com reports. The fund owned 83,944 shares of the financial services provider’s stock after acquiring an additional 4,047 shares during the quarter. HighTower Advisors LLC’s holdings in iShares Biotechnology ETF were worth $11,098,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of IBB. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $29,000. HHM Wealth Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $32,000. Newbridge Financial Services Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter worth $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $134.19 on Monday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The stock has a market capitalization of $6.34 billion, a P/E ratio of 24.52 and a beta of 0.84. The stock has a fifty day moving average of $136.25 and a 200-day moving average of $139.76.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.